Fig. 8.
Ability of MX-2401 to interact with model membranes. (A) Dose-dependent lipid flip-flop of C6-NBD-PC asymmetrically labeled POPC/POPG liposomes treated with MX-2401, daptomycin, and GMS in the presence of 5 mM CaCl2. (B) Dose-dependent calcein release from POPC/POPG liposomes treated with MX-2401, daptomycin, and GMS in the presence of 5 mM CaCl2. The error bars indicate standard deviations.